ROYAL BANK OF CANADA - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 26 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,000
-33.3%
805
-8.9%
0.00%
Q2 2023$3,000
+200.0%
884
+9.8%
0.00%
Q1 2023$1,0000.0%8050.0%0.00%
Q4 2022$1,0000.0%805
-30.6%
0.00%
Q3 2022$1,000
-50.0%
1,160
+44.1%
0.00%
Q2 2022$2,0000.0%8050.0%0.00%
Q1 2022$2,000
-33.3%
8050.0%0.00%
Q4 2021$3,000
-66.7%
805
-65.1%
0.00%
Q3 2021$9,000
-10.0%
2,3050.0%0.00%
Q2 2021$10,000
-41.2%
2,305
+27.7%
0.00%
Q1 2021$17,000
+112.5%
1,805
+113.4%
0.00%
Q4 2020$8,000
-27.3%
846
-68.7%
0.00%
Q3 2020$11,000
-31.2%
2,699
+11.8%
0.00%
Q2 2020$16,000
+128.6%
2,415
-13.7%
0.00%
Q1 2020$7,000
-36.4%
2,799
+19.3%
0.00%
Q4 2019$11,000
+120.0%
2,347
+6.9%
0.00%
Q3 2019$5,000
-50.0%
2,196
+13.8%
0.00%
Q2 2019$10,000
+11.1%
1,9300.0%0.00%
Q1 2019$9,000
+800.0%
1,930
+283.7%
0.00%
Q4 2018$1,0005030.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,146,470$4,861,0005.06%
Corriente Advisors, LLC 730,000$3,095,0001.57%
Manatuck Hill Partners, LLC 571,500$2,423,0001.11%
CVI Holdings, LLC 276,176$1,171,0000.48%
DAFNA Capital Management LLC 156,529$664,0000.22%
Worth Venture Partners, LLC 42,887$182,0000.15%
Granite Point Capital Management, L.P. 646,855$2,743,0000.15%
Ikarian Capital, LLC 415,000$1,759,0000.13%
Maven Securities LTD 359,285$1,473,0000.12%
Nantahala Capital Management 756,193$3,206,0000.10%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders